» Articles » PMID: 35939806

Potent Activation of NAD-Dependent Deacetylase Sirt7 by Nucleosome Binding

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2022 Aug 8
PMID 35939806
Authors
Affiliations
Soon will be listed here.
Abstract

Sirtuin-7 (Sirt7) is a nuclear NAD-dependent deacetylase with a broad spectrum of biological functions. Sirt7 overexpression is linked to several pathological states and enhances anticancer drug resistance, making the enzyme a promising target for the development of novel therapeutics. Despite a plethora of reported functions, the biochemical characterization of recombinant Sirt7 remains inadequate for the development of novel drug candidates. Here, we conduct an extensive biochemical analysis of Sirt7 using newly developed binding and kinetic assays to reveal that the enzyme preferentially interacts with and is activated by nucleosomes. Sirt7 activation by nucleic acids alone is effective toward long-chain acylated hydrophobic substrates, while only nucleosome binding leads to 10-fold activation of the deacetylase activity. Using endogenous chromatin and recombinant acetylated nucleosomes, we reveal that Sirt7 is one of the most efficient deacetylases in the sirtuin family and that its catalytic activity is limited by the rate of dissociation from deacetylated nucleosomes.

Citing Articles

Structural basis of SIRT7 nucleosome engagement and substrate specificity.

Moreno-Yruela C, Ekundayo B, Foteva P, Ni D, Calvino-Sanles E, Stahlberg H Nat Commun. 2025; 16(1):1328.

PMID: 39900593 PMC: 11790868. DOI: 10.1038/s41467-025-56529-y.


Activation and inhibition of sirtuins: From bench to bedside.

Fiorentino F, Fabbrizi E, Mai A, Rotili D Med Res Rev. 2024; 45(2):484-560.

PMID: 39215785 PMC: 11796339. DOI: 10.1002/med.22076.


YZL-51N functions as a selective inhibitor of SIRT7 by NAD competition to impede DNA damage repair.

Kang T, Yan Y, Tian Y, Zhang J, Zhang M, Shu Y iScience. 2024; 27(6):110014.

PMID: 38947512 PMC: 11214487. DOI: 10.1016/j.isci.2024.110014.


Current Trends in Sirtuin Activator and Inhibitor Development.

Bursch K, Goetz C, Smith B Molecules. 2024; 29(5).

PMID: 38474697 PMC: 10934002. DOI: 10.3390/molecules29051185.

References
1.
Kalashnikova A, Porter-Goff M, Muthurajan U, Luger K, Hansen J . The role of the nucleosome acidic patch in modulating higher order chromatin structure. J R Soc Interface. 2013; 10(82):20121022. PMC: 3627075. DOI: 10.1098/rsif.2012.1022. View

2.
Tong Z, Wang M, Wang Y, Kim D, Grenier J, Cao J . SIRT7 Is an RNA-Activated Protein Lysine Deacylase. ACS Chem Biol. 2016; 12(1):300-310. PMC: 5326686. DOI: 10.1021/acschembio.6b00954. View

3.
Zhao J, Wozniak A, Adams A, Cox J, Vittal A, Voss J . SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway. J Exp Clin Cancer Res. 2019; 38(1):252. PMC: 6567523. DOI: 10.1186/s13046-019-1246-4. View

4.
Li W, Sun Z, Chen C, Wang L, Geng Z, Tao J . Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells. Biomed Pharmacother. 2018; 100:257-266. DOI: 10.1016/j.biopha.2018.02.007. View

5.
Dyer P, Edayathumangalam R, White C, Bao Y, Chakravarthy S, Muthurajan U . Reconstitution of nucleosome core particles from recombinant histones and DNA. Methods Enzymol. 2004; 375:23-44. DOI: 10.1016/s0076-6879(03)75002-2. View